Clinical Trials Logo

Total Knee Arthroplasty clinical trials

View clinical trials related to Total Knee Arthroplasty.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06460350 Not yet recruiting - Clinical trials for Total Knee Arthroplasty

NEUROCUPLE™ in TKA Patients

Start date: June 24, 2024
Phase: N/A
Study type: Interventional

This is a randomized (1:1) placebo-controlled clinical trial to determine the feasibility and effectiveness of 30-day application of NEUROCUPLE™ patch for pain reduction and opioid consumption following TKA. Results will establish NEUROCUPLE™ as an effective non-opioid postoperative pain management device for FDA approval. Importantly, we have a placebo device (device without the captor array layer) that looks exactly like the active device, allowing us to conduct a true placebo randomized study.

NCT ID: NCT06371950 Not yet recruiting - Inflammation Clinical Trials

Gut Microbiome in Orthopaedics

GUMBO
Start date: May 1, 2024
Phase: N/A
Study type: Interventional

Patients having knee replacement surgery regularly experience joint pain and compromised bone quality leading to implant loosening and periprosthetic fractures. The role of the gut microbiome, which is the collection of bacteria and other microbes within the human gastrointestinal tract, is just beginning to be recognized, including its potential effects on pain, infection, and loosening after total joint replacement. Antibiotics are regularly used in orthopaedic surgery to reduce the risk of infection, but they also harm gut microbiota and reduce their potentially beneficial effects. Probiotics may have a role to play in enhancing bone quality and decreasing synovial inflammation after joint replacement surgery, and this study will explore the potential relationship of probiotic use with implant migration, bone density, and patient outcomes. This study is a randomized, controlled, double-blinded trial comparing probiotic use with placebo in post-menopausal women undergoing primary total knee replacement. The main questions it aims to answer are: - to compare implant migration between groups from baseline to six weeks post-surgery - to compare bone density and joint inflammation between groups from baseline to six weeks post-surgery - to compare gut microbiome composition and patient-reported outcome measures between groups from baseline to six weeks post-surgery

NCT ID: NCT06305065 Not yet recruiting - Knee Osteoarthritis Clinical Trials

Open and Closed Platform Robotic-assisted Versus Conventional Total Knee Arthroplasty

Start date: March 2024
Phase: N/A
Study type: Interventional

REAL INTELLIGENCE™ CORI™ (CORI Surgical System) is a computer-assisted orthopedic surgical system. CORI Surgical System is designed to aid surgeons in planning and executing a procedure involving bone preparation for total knee arthroplasty (TKA) procedures. CORI Surgical System is comprised of a console control unit, optical tracking camera, primary and secondary input displays (tablet and optional display monitor), and foot pedal. The CORI Surgical System software consists of a patient and user management module, a surgical planner, and an intra-operative cutting module. Yuanhua Orthopaedic Robotic Systems, KUNWU, is an open-platform robotic system that does not restrict surgeons in choosing the type of prosthesis implant. It is the only Orthopaedic Robotic System in Hong Kong registered with the HK Department of Health Medical Devices Control Office (MDCO) as an open platform system. Unlike other manufacturer's implant-based robots (closed systems), Yuanhua's objective is to provide maximum flexibility in choosing the best implant for each patient. Closed system robots not only impact the surgeon's choice of implant for an individual patient but also affect the hospital's implant purchases over multiple years without any negotiation power on pricing. This business model is often referred to as a "razor and razor blade" model. The primary objective of this study is to evaluate the use of open and closed platform robotic-assisted TKA procedure in achieving post-operative leg alignment as compared to procedures using standard instruments. The secondary objective of this study is to assess the safety and performance of the robotic-assisted TKA procedure up to 12 months after surgery as compared to procedures using conventional manual instruments.

NCT ID: NCT06083480 Not yet recruiting - Clinical trials for Osteoarthritis, Knee

Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty

Start date: June 15, 2024
Phase: Phase 4
Study type: Interventional

This is a prospective randomized controlled trial that will assess preoperative, perioperative, and long-term oxidative stress (OS); pain; and functional outcomes over a 12 month period and test the hypothesis that a potent antioxidant intervention (glycine + N-acetyl-cysteine(GlyNAC)) reduces oxidative stress and chronic post surgical pain (CPSP) in patients undergoing total knee arthroplasty (TKA).

NCT ID: NCT06080152 Not yet recruiting - Clinical trials for Total Knee Arthroplasty

Effect of Walker vs Wheeled Device on Mobility After Total Knee Arthroplasty

Start date: May 2024
Phase: N/A
Study type: Interventional

Maneuverability is currently under appreciated by patients who are seeking mobility. This pilot study is examining how patients maneuverability and mobility will change with this novel mobility tool - A-Linker compared to the standard of care walker.

NCT ID: NCT06002724 Not yet recruiting - Acute Pain Clinical Trials

Feasibility Study of Peripheral Venous Cannulation Pain in Predicting Acute Pain After Total Knee Arthroplasty

Start date: August 30, 2023
Phase:
Study type: Observational

The goal of this prospective observational study is to explore the feasibility of preoperative peripheral venous cannulation pain score in predicting acute pain after total knee arthroplasty, including resting pain and movement-evoked pain.

NCT ID: NCT05911438 Not yet recruiting - Clinical trials for Total Knee Arthroplasty

Accelerated Recovery for Total Knee Replacement Surgery With Preoperative Intravenous Iron Combined With Human Erythropoietin for Rapid Hematopoietic Mobilization to Prevent Postoperative Anemia

Hematoboost
Start date: July 2023
Phase: N/A
Study type: Interventional

This study is a randomized, placebo-controlled, multicenter research design to investigate the effectiveness and safety of a single-dose intravenous iron combined with HuEPO hematopoietic mobilization before surgery in patients undergoing unilateral total knee arthroplasty for the first time.

NCT ID: NCT05833152 Not yet recruiting - Clinical trials for Total Knee Arthroplasty

Correlation Between Preoperative Knee Extension Lag and Functional Outcome After Total Knee Arthroplasty

Start date: April 17, 2023
Phase:
Study type: Observational

To explore the relationship between different knee extension hysteresis angles and functional outcome of knee joint after total knee replacement

NCT ID: NCT05581563 Not yet recruiting - Clinical trials for Total Knee Arthroplasty

Clinical and Functional Outcomes of Tourniquet Use in Primary Total Knee Arthroplasty

Start date: October 10, 2022
Phase: N/A
Study type: Interventional

Many surgeons choose to perform total knee arthroplasty (TKA) surgery with the aid of a tourniquet. A tourniquet is a device that fits around the leg and restricts blood flow to the limb. There is a need to understand whether tourniquets are safe, and if they benefit, or harm, patients. The aim of this study was to determine the benefits and harms of tourniquet use in TKA surgery

NCT ID: NCT05517278 Not yet recruiting - Clinical trials for Total Knee Arthroplasty

Clinical Evaluation of the Next Science SurgX Antimicrobial Wound Gel Impact on Surgical Site Complications

Start date: January 2024
Phase: N/A
Study type: Interventional

This is a single-site, prospective, clinical study of subjects that are scheduled to undergo either total hip or total knee arthroplasties. It is anticipated that surgical wounds treated with SurgX will exhibit reduced surgical site complication rates and improved post-operative treatment outcomes by potentially decreasing site bioburden of both free-floating and biofilm-entrenched organisms.